Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122600) titled 'A Randomized, Open-label, Controlled Study of GBE50 in the Treatment of Cerebral Small Vessel Disease' on April 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Cerebral Small Vessel Disease (CSVD)
Intervention:
Control group:Aspirin
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-23
Target Sample Size: Control group:20;experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=296130
Publis...